Recommendations for optimal warfarin management for prevention of thromboembolic events in patients with atrial fibrillation
The objective of this report is to provide recommendations for the optimal management of warfarin for the prevention of thromboembolic events in patients with atrial fibrillation (AF). Three specific questions were asked to CADTH COMPUS Expert Review Committee (CERC) members: 1. Question 1: What is...
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2011, November 2011
|
| Series: | CADTH optimal use report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this report is to provide recommendations for the optimal management of warfarin for the prevention of thromboembolic events in patients with atrial fibrillation (AF). Three specific questions were asked to CADTH COMPUS Expert Review Committee (CERC) members: 1. Question 1: What is the role of specialized anticoagulation services or other anticoagulation management options for the optimal management of warfarin therapy? 2. Question 2: What is the role of patient self-testing and patient self-management for the optimal management of warfarin therapy? 3. Question 3: In remote areas, what types of anticoagulation management options can be recommended? |
|---|---|
| Item Description: | "This report was prepared by the Canadian Agency for Drugs and Technologies in Health (CADTH)"--T.p. verso |
| Physical Description: | 1 PDF file (i, 20 pages) |